Intestinal worms can cause symptoms such as anaemia, intestinal obstruction, inflammation of the colon, impaired development, and even death. Our NTD programmes aim to target entire communities of at-risk men, women and children to eliminate these diseases.
In 2022, Sightsavers treated more than 14 million people for intestinal worms, and trained more than 225,000 local volunteers to distribute medication through mass drug administration to treat a range of neglected tropical diseases, including intestinal worms. Medication is also distributed in schools, and the disease is frequently treated at the same time as schistosomiasis.
As part of our community and school programmes, we aim to educate local communities about the importance of hygiene to stop the spread of disease. Access to and use of clean water and sanitation, as well as good hygienic practices such as wearing shoes and washing hands, is vital for preventing and controlling the spread of intestinal worms.
Sightsavers has been awarded $16.9 million to continue and expand its deworming work, after a funding recommendation from US charity evaluator GiveWell.
Charity evaluator GiveWell has provided a further US$7.8 million to fight intestinal worms and schistosomiasis in Nigeria and Cameroon.
Ndellejong Cosmas Eljong, Sightsavers’ technical adviser for schistosomiasis and intestinal worms, tells us via video about his work to fight parasitic worm infections and how deworming can have a huge impact on communities around the world.